Sequential degradation of raw vinasse by a laccase enzyme producing fungus Pleurotus sajor-caju and its ATPS purification

Autor: Joberson Alves Junior, Yago Araujo Vieira, Ianny Andrade Cruz, Débora da Silva Vilar, Mario M. Aguiar, Nádia Hortense Torres, Ram Naresh Bharagava, Álvaro Silva Lima, Ranyere Lucena de Souza, Luiz Fernando Romanholo Ferreira

Publikováno v: Biotechnology Reports, Vol 25, Iss , Pp - (2020)

This study evaluated simultaneously the raw vinasse degradation, an effluent from the sugar-alcohol industry, the laccase production by Pleurotus sajor-caju and its purification using aqueous two-phase systems (ATPS). To improve laccase production, d

Externí odkaz: https://doaj.org/article/16c61616b793497d89583461cd33c787

Biomimetic Analogues of the Desferrioxamine E Siderophore for PET Imaging of Invasive Aspergillosis: Targeting Properties and Species Specificity.

Autor: Mular A; Faculty of Chemistry, University of Wrocław, 50-383 Wrocław, Poland., Hubmann I; Department of Nuclear Medicine, Medical University Innsbruck, A-6020 Innsbruck, Austria., Petrik M; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and Czech Advanced Technology and Research Institute, Palacky University, 77900 Olomouc, Czech Republic., Bendova K; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and Czech Advanced Technology and Research Institute, Palacky University, 77900 Olomouc, Czech Republic., Neuzilova B; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and Czech Advanced Technology and Research Institute, Palacky University, 77900 Olomouc, Czech Republic., Aguiar M; Department of Nuclear Medicine, Medical University Innsbruck, A-6020 Innsbruck, Austria.; Institute of Molecular Biology, Biocenter, Medical University Innsbruck, A-6020 Innsbruck, Austria., Caballero P; Institute of Molecular Biology, Biocenter, Medical University Innsbruck, A-6020 Innsbruck, Austria., Shanzer A; Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot 7610001, Israel., Kozłowski H; Faculty of Chemistry, University of Wrocław, 50-383 Wrocław, Poland.; Public Higher Medical Professional School in Opole, Katowicka 68, 45-060 Opole, Poland., Haas H; Institute of Molecular Biology, Biocenter, Medical University Innsbruck, A-6020 Innsbruck, Austria., Decristoforo C; Department of Nuclear Medicine, Medical University Innsbruck, A-6020 Innsbruck, Austria., Gumienna-Kontecka E; Faculty of Chemistry, University of Wrocław, 50-383 Wrocław, Poland.

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2024 Jul 25; Vol. 67 (14), pp. 12143-12154. Date of Electronic Publication: 2024 Jun 22.

Development of a rare disease algorithm to identify persons at risk of Gaucher disease using electronic health records in the United States.

Autor: Wilson A; Health Economics and Value Assessment, Sanofi, Cambridge, MA, USA., Chiorean A; Quinten Health, Paris, France., Aguiar M; Global Medical Affairs, RD Hematology, Sanofi, Cambridge, MA, USA., Sekulic D; Global Medical Affairs, RD Hematology, Sanofi, Cambridge, MA, USA., Pavlick P; US Rare Medical, Sanofi, Cambridge, MA, USA., Shah N; Medical Diagnostics, Sanofi, Cambridge, MA, USA., Sniderman King L; US Rare Medical, Sanofi, Cambridge, MA, USA., Génin M; Quinten Health, Paris, France., Rollot M; Quinten Health, Paris, France., Blanchon M; Quinten Health, Paris, France., Gosset S; Quinten Health, Paris, France., Montmerle M; Quinten Health, Paris, France., Molony C; Digital Data Science, Sanofi, Cambridge, MA, USA., Dumitriu A; Global Medical Affairs, Medical Evidence Generation, Sanofi, Cambridge, MA, USA. Alexandra.Dumitriu@sanofi.com.

Publikováno v: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2023 Sep 09; Vol. 18 (1), pp. 280. Date of Electronic Publication: 2023 Sep 09.

Uptake of the Siderophore Triacetylfusarinine C, but Not Fusarinine C, Is Crucial for Virulence of Aspergillus fumigatus.

Autor: Aguiar M; Institute of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria., Orasch T; Institute of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria., Shadkchan Y; Department of Clinical Microbiology and Immunology, Sackler School of Medicine Ramat-Aviv, Tel Aviv, Israel., Caballero P; Institute of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria., Pfister J; Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria., Sastré-Velásquez LE; Institute of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria., Gsaller F; Institute of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria., Decristoforo C; Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria., Osherov N; Department of Clinical Microbiology and Immunology, Sackler School of Medicine Ramat-Aviv, Tel Aviv, Israel., Haas H; Institute of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.

Publikováno v: MBio [mBio] 2022 Oct 26; Vol. 13 (5), pp. e0219222. Date of Electronic Publication: 2022 Sep 20.

Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis.

Autor: Ortiz A; Unidad de Diálisis, IIS-Fundación Jiménez Díaz, School of Medicine, UAM, IRSIN and REDINREN, Madrid, Spain., Kanters S; Evidence Synthesis and Decision Modeling, Precision HEOR, Vancouver, BC, Canada., Hamed A; Sanofi Genzyme Health Economics and Value Assessment, Genzyme, Cambridge, MA, USA., DasMahapatra P; Sanofi Genzyme Health Economics and Value Assessment, Genzyme, Cambridge, MA, USA., Poggio E; Biostatistical Consulting Inc., Lexington, MA, USA., Maski M; Sanofi Genzyme Medical Affairs, Genzyme, Cambridge, MA, USA., Aguiar M; Sanofi Genzyme Medical Affairs, Genzyme, Cambridge, MA, USA., Ponce E; Sanofi Genzyme Medical Affairs, Genzyme, Cambridge, MA, USA., Jansen JP; Evidence Synthesis and Decision Modeling, Precision HEOR, Oakland, CA, USA., Ayers D; Evidence Synthesis and Decision Modeling, Precision HEOR, Vancouver, BC, Canada., Goldgrub R; Evidence Synthesis and Decision Modeling, Precision HEOR, Vancouver, BC, Canada., Desnick RJ; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Publikováno v: Clinical kidney journal [Clin Kidney J] 2020 May 22; Vol. 14 (4), pp. 1136-1146. Date of Electronic Publication: 2020 May 22 (Print Publication: 2021).